Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience
Background Little is known about patients discharged to hospice following hospitalization for complications of cirrhosis. Aim We sought to understand the current pattern of hospice utilization in patients with cirrhosis by evaluating the North American Consortium for the Study of End-stage Liver Disease (NACSELD) cohort. Methods Patients with cirrhosis from 14 tertiary-care hepatology centers across North America non-electively hospitalized and prospectively enrolled were evaluated. Exclusion criteria included HIV infection, transplantation or non-hepatic malignancy. Random computer-based propensity score matching was undertaken in a 1:2 ratio based on admission MELD score ± 3 points. Results Totally, 2718 patients were enrolled, 5% (N = 132) were discharged to hospice, 6% (N = 171) died, and the rest were discharged alive. Patients discharged to hospice were older (60 vs. 57 years, p = 0.04), less likely to have had SBP (13% vs. 28%, p = 0.002) and be listed for liver transplantation (11% vs. 26%, p = 0.0007). Features, on multivariable modeling, associated with increased probability of discharge to hospice as opposed to being discharged alive: grade-3–4 hepatic encephalopathy, a higher Child–Turcotte–Pugh (CTP) score, and a higher discharge serum creatinine; however, a higher serum sodium, being listed for transplant and being prescribed rifaximin or a statin were protective from hospice discharge. Conclusion Patients with more advanced liver disease, hepatic encephalopathy, renal dysfunction, and those not candidates for liver transplantation were more likely to be discharged to hospice. However, in this sick multinational cohort of cirrhotic inpatients, it seems that hospice is markedly underutilized (5%) since 25% of patients not discharged to hospice died within 6 months..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Digestive diseases and sciences - 65(2020), 9 vom: 07. März, Seite 2571-2579 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O’Leary, Jacqueline G. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2020 |
|---|
| doi: |
10.1007/s10620-020-06168-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2118849656 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2118849656 | ||
| 003 | DE-627 | ||
| 005 | 20230504162532.0 | ||
| 007 | tu | ||
| 008 | 230504s2020 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10620-020-06168-8 |2 doi | |
| 035 | |a (DE-627)OLC2118849656 | ||
| 035 | |a (DE-He213)s10620-020-06168-8-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a O’Leary, Jacqueline G. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2020 | ||
| 520 | |a Background Little is known about patients discharged to hospice following hospitalization for complications of cirrhosis. Aim We sought to understand the current pattern of hospice utilization in patients with cirrhosis by evaluating the North American Consortium for the Study of End-stage Liver Disease (NACSELD) cohort. Methods Patients with cirrhosis from 14 tertiary-care hepatology centers across North America non-electively hospitalized and prospectively enrolled were evaluated. Exclusion criteria included HIV infection, transplantation or non-hepatic malignancy. Random computer-based propensity score matching was undertaken in a 1:2 ratio based on admission MELD score ± 3 points. Results Totally, 2718 patients were enrolled, 5% (N = 132) were discharged to hospice, 6% (N = 171) died, and the rest were discharged alive. Patients discharged to hospice were older (60 vs. 57 years, p = 0.04), less likely to have had SBP (13% vs. 28%, p = 0.002) and be listed for liver transplantation (11% vs. 26%, p = 0.0007). Features, on multivariable modeling, associated with increased probability of discharge to hospice as opposed to being discharged alive: grade-3–4 hepatic encephalopathy, a higher Child–Turcotte–Pugh (CTP) score, and a higher discharge serum creatinine; however, a higher serum sodium, being listed for transplant and being prescribed rifaximin or a statin were protective from hospice discharge. Conclusion Patients with more advanced liver disease, hepatic encephalopathy, renal dysfunction, and those not candidates for liver transplantation were more likely to be discharged to hospice. However, in this sick multinational cohort of cirrhotic inpatients, it seems that hospice is markedly underutilized (5%) since 25% of patients not discharged to hospice died within 6 months. | ||
| 650 | 4 | |a Cirrhosis | |
| 650 | 4 | |a Palliative care | |
| 650 | 4 | |a ACLF | |
| 650 | 4 | |a NACSELD | |
| 650 | 4 | |a Decompensation | |
| 700 | 1 | |a Tandon, Puneeta |4 aut | |
| 700 | 1 | |a Reddy, K. Rajender |4 aut | |
| 700 | 1 | |a Biggins, Scott W. |4 aut | |
| 700 | 1 | |a Wong, Florence |4 aut | |
| 700 | 1 | |a Kamath, Patrick S. |4 aut | |
| 700 | 1 | |a Garcia-Tsao, Guadalupe |4 aut | |
| 700 | 1 | |a Maliakkal, Benedict |4 aut | |
| 700 | 1 | |a Lai, Jennifer |4 aut | |
| 700 | 1 | |a Fallon, Michael |4 aut | |
| 700 | 1 | |a Vargas, Hugo E. |4 aut | |
| 700 | 1 | |a Thuluvath, Paul |4 aut | |
| 700 | 1 | |a Subramanian, Ram |4 aut | |
| 700 | 1 | |a Thacker, Leroy R. |4 aut | |
| 700 | 1 | |a Bajaj, Jasmohan S. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Digestive diseases and sciences |d Springer US, 1979 |g 65(2020), 9 vom: 07. März, Seite 2571-2579 |w (DE-627)129894036 |w (DE-600)304250-9 |w (DE-576)015213218 |x 0163-2116 |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2020 |g number:9 |g day:07 |g month:03 |g pages:2571-2579 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s10620-020-06168-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2020 |e 9 |b 07 |c 03 |h 2571-2579 | ||